Statin, testosterone and phosphodiesterase 5-inhibitor treatments and age related mortality in diabetes

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 3

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Diabetes. Mar 15, 2017; 8(3): 104-111
Published online Mar 15, 2017. doi: 10.4239/wjd.v8.i3.104

Full Size Figure Download Figure

Figure 1 Association between Ln (mortality rate) and age.

Citation: Hackett G, Jones PW, Strange RC, Ramachandran S. Statin, testosterone and phosphodiesterase 5-inhibitor treatments and age related mortality in diabetes. World J Diabetes 2017; 8(3): 104-111
URL: https://www.wjgnet.com/1948-9358/full/v8/i3/104.htm
DOI: https://dx.doi.org/10.4239/wjd.v8.i3.104

Hackett G, Jones PW, Strange RC, Ramachandran S. Statin, testosterone and phosphodiesterase 5-inhibitor treatments and age related mortality in diabetes. World J Diabetes 2017; 8(3): 104-111 [PMID: 28344753 DOI: 10.4239/wjd.v8.i3.104]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.